New Best Practice Awards for innovative use of healthcare data

Applications are now open for the PRECISEU Best Practice Awards 2025 – and we want to see your success story!

We’re proud to be one of the partners in the PRECISEU project, which supports the implementation of personalized and precision medicine across Europe. These awards will showcase transformative practices and accelerate outstanding innovation in healthcare data utilization, set to culminate in a recognition ceremony during the project’s General Assembly in Vilnius this September.

These awards are a great opportunity to showcase your organization’s work and gain recognition at the European level, with four award categories:

    • IMPACT: for academic-business partnerships driving significant healthcare improvements
    • INNOVATION: for SMEs and start-ups revolutionising patient care with advanced therapy medicinal products (ATMPs)
    • CULTURE: for organizations that have highly developed patient involvement and public engagement
    • EXCELLENCE: for organizations leading in health data accessibility, safety and inclusivity.

Eligibility extends to public and private research-performing organizations from EU Member States or Horizon Europe-associated countries. The winners will receive Europe-wide recognition, mentoring opportunities and participation in key conferences.

Applications open

Applications are currently open, with the winners announced in September.

Info sessions

PRECISEU is hosting two online info sessions where you can learn more about the application process, criteria and how your initiative could be selected as a best practice across Europe.

  • Info Session 1: Wednesday30 April 2025, 9.30 (register here)
  • Info Session 2: Monday, 12 May 2025, 11.00 (register here)

If you’re pushing boundaries in personalized and data-driven ATMP-based solutions in healthcare, this is your moment! Don’t miss it!

Share this article

More news on this topic

Better together

and are joining forces in a brand new organization

The members of MEDVIA and flanders.bio have voted to merge their activities in the first half of 2025. With a united voice, we will champion the entire healthtech and biotech ecosystem on the regional, federal and European stage.

The merger allows MEDVIA and flanders.bio to align activities and deliver more powerful support for our collective members. We will achieve greater impact with more dynamic networking opportunities, better directed funding and increased efficiency, sharpening our focus in common areas and drafting strategic roadmaps for Flanders.